ANTIOS THERAPEUTICS

antios-therapeutics-logo

Antios Therapeutics is a biopharmaceutical company devoted to developing innovative therapies for viral diseases. With an experienced and proven leadership team, the company is focused on the development of its oral drug candidate for potentially curative treatment of HBV infections. Antios Therapeutics was founded by Abel De La Rosa, Douglas Mayers, and Idean Marvasty.

#SimilarOrganizations #People #Financial #Event #Website #More

ANTIOS THERAPEUTICS

Social Links:

Industry:
Biopharma Biotechnology Therapeutics

Founded:
2018-01-01

Address:
Atlanta, Georgia, United States

Country:
United States

Website Url:
http://www.antiostherapeutics.com

Total Employee:
11+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
200.4 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Wordpress Plugins Mobile Non Scaleable Content Nginx Sitelinks Search Box


Similar Organizations

aclaris-therapeutics-logo

Aclaris Therapeutics

Aclaris Therapeutics is a specialty pharmaceutical company engaged in developing dermatologic therapies.

adamis-pharmaceuticals-logo

Adamis Pharmaceuticals

Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.

chiasma-logo

Chiasma

Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.

ocera-therapeutics-logo

Ocera Therapeutics

Ocera Therapeutics is a biopharmaceutical company developing novel therapeutics for patients with acute and chronic liver diseases.

proteostasis-therapeutics-logo

Proteostasis Therapeutics

Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.

silverback-therapeutics-logo

Silverback Therapeutics

Silverback Therapeutics is a biopharmaceutical company that develops ImmunoTAC therapies targeting previously inaccessible disease pathways.

simcha-therapeutics-logo

Simcha Therapeutics

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.


Current Advisors List

craig-gordon_image

Craig Gordon Board Member @ Antios Therapeutics
Board_member
2021-11-01

henry-chen_image

Henry Chen Board of Directors @ Antios Therapeutics
Board_member

nicole-vitullo_image

Nicole Vitullo Board of Directors @ Antios Therapeutics
Board_member

scott-morenstein_image

Scott Morenstein Board of Directors @ Antios Therapeutics
Board_member

not_available_image

Abel De La Rosa Co-Founder, CEO & Board of Directors @ Antios Therapeutics
Board_member

benjamin-rovinski-phd_image

Benjamin Rovinski, Ph.D. Board of Directors @ Antios Therapeutics
Board_member

Current Employees Featured

catherine-coffey-ross_image

Catherine Coffey Ross
Catherine Coffey Ross VP, Medical Affairs @ Antios Therapeutics
VP, Medical Affairs
2021-08-01

idean-marvasty_image

Idean Marvasty
Idean Marvasty Co-founder @ Antios Therapeutics
Co-founder

not_available_image

Douglas Mayers
Douglas Mayers Co-Founder and Chief Medical Officer @ Antios Therapeutics
Co-Founder and Chief Medical Officer

greg-mayes_image

Greg Mayes
Greg Mayes President and CEO @ Antios Therapeutics
President and CEO

Founder


not_available_image

Abel De La Rosa

not_available_image

Douglas Mayers

idean-marvasty_image

Idean Marvasty

Investors List

epiq-capital-group_image

EPIQ Capital Group

EPIQ Capital Group investment in Series B - Antios Therapeutics

altium-capital_image

Altium Capital

Altium Capital investment in Series B - Antios Therapeutics

domain-associates_image

Domain Associates

Domain Associates investment in Series B - Antios Therapeutics

heartland-healthcare-capital_image

Heartland Healthcare Capital

Heartland Healthcare Capital investment in Series B - Antios Therapeutics

pontifax_image

Pontifax

Pontifax investment in Series B - Antios Therapeutics

gra-venture-fund-llc_image

GRA Venture Fund, LLC

GRA Venture Fund, LLC investment in Series B - Antios Therapeutics

gordonmd-global-investments_image

GordonMD Global Investments

GordonMD Global Investments investment in Series B - Antios Therapeutics

avego-bioscience-capital_image

Avego Bioscience Capital

Avego Bioscience Capital investment in Series B - Antios Therapeutics

fonds-de-solidarit-ftq_image

Fonds de solidaritรฉ FTQ

Fonds de solidaritรฉ FTQ investment in Series B - Antios Therapeutics

amzak-health-investors_image

Amzak Health Investors

Amzak Health Investors investment in Series B - Antios Therapeutics

Key Employee Changes

Date New article
2021-08-10 Antios Therapeutics Appoints Catherine Coffey Ross as VP, Medical Affairs

Official Site Inspections

http://www.antiostherapeutics.com Semrush global rank: 5.79 M Semrush visits lastest month: 1.44 K

  • Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
  • IP address: 15.197.148.33
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Antios Therapeutics" on Search Engine